Free Trial
NASDAQ:JSPRW

Jasper Therapeutics (JSPRW) Stock Price, News & Analysis

$0.19
0.00 (0.00%)
(As of 05/23/2024 ET)
Today's Range
$0.17
$0.19
50-Day Range
$0.12
$0.24
52-Week Range
$0.04
$0.38
Volume
3,737 shs
Average Volume
28,027 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Jasper Therapeutics

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and conditioning regimens for stem cell transplantation. In addition, it is also developing stem cell transplants for rare diseases such as sickle cell disease, fanconi anemia, chronic granulomatous diseases, and GATA2 MDS, and severe combined immunodeficiency. Jasper Therapeutics, Inc. is headquartered in Redwood City, California.

JSPRW Stock Price History

JSPRW Stock News Headlines

See More Headlines
Receive JSPRW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:JSPRW
Web
N/A
Fax
N/A
Employees
45
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Ronald A. Martell (Age 62)
    President, CEO & Director
    Comp: $892.45k
  • Mr. Herbert C. Cross (Age 52)
    CFO & Corporate Secretary
  • Dr. Luca Di Noto Ph.D.
    Senior Vice President of Technical Operations
  • Mr. David Ku M.D.
    Vice President of Corporate Development, Portfolio Strategy & Management
  • Mr. Matthew Ford
    Vice President of Human Resources
  • Dr. Wendy Pang M.D.
    Ph.D., Senior Vice President of Research & Translational Medicine
  • Dr. Edwin Jonathan Tucker M.D. (Age 52)
    Chief Medical Officer
  • Ms. Patricia Carlos
    Senior Vice President of Regulatory Affairs & Quality

JSPRW Stock Analysis - Frequently Asked Questions

How have JSPRW shares performed in 2024?

Jasper Therapeutics' stock was trading at $0.08 at the beginning of 2024. Since then, JSPRW stock has increased by 137.1% and is now trading at $0.1897.
View the best growth stocks for 2024 here
.

How do I buy shares of Jasper Therapeutics?

Shares of JSPRW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:JSPRW) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners